Ord/Allergan PLC (NYSE:AGN) on 01/25/2019 declared a dividend of $ 0.7400 per share payable on March 15, 2019 to shareholders of record as of February 15, 2019. Dividend amount recorded is an increase of $ 0.02 from last dividend Paid.

Ord/Allergan PLC (NYSE:AGN) has paid dividends since 1989, has a current dividend yield of 1.8404518366% and has increased its dividends for 1 successive years.

Ord/Allergan PLC's market cap is $ 53,146,155,020 and has a PE ratio of 23.87. The stock price closed yesterday at $ 157.57 and has a 52 week low/high of $ 125.84 and $ 197.00.

Allergan is a pharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Co. operates and manages its business in three operating segments: U.S. Specialized Therapeutics, which provides medical aesthetics, medical dermatology, eye care, neurosciences and urology therapeutic products; U.S. General Medicine, which focuses on newly developed pharmaceutical products; and International, which provides an array of aesthetics products outside of the U.S. Co.'s portfolio of products include Alloderm® for skin graft and Alphagan®/Combigan® as selective alpha2 agonist.

For more information on Ord/Allergan PLC click here.